Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
about
Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmissionHormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisHormonal contraception for women exposed to HIV infectionHormonal contraception for women exposed to HIV infectionPreconception and contraceptive care for women living with HIVMicrobicides and their potential as a catalyst for multipurpose sexual and reproductive health technologiesContraceptive methods and risk of HIV acquisition or female-to-male transmissionIncreases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive TractIncidence of herpes simplex virus type 2 infections in Africa: a systematic reviewAsking the right questions: developing evidence-based strategies for treating HIV in women and childrenWomen and HIV in Sub-Saharan Africa.Greentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice.Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studiesOral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk?Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying PracticesA prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in KenyaProspective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women.Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African womenA randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.The effects of reproductive hormones on the physical properties of cervicovaginal fluid.Hormonal contraception and HIV acquisition: reanalysis using marginal structural modelingBroadening the debate over HIV and hormonal contraception.Loss to follow-up as a competing risk in an observational study of HIV-1 incidenceHormonal contraception and area of cervical ectopy: a longitudinal assessment.Hormonal contraception and HIV-1 transmission.Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraceptionProgesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression.Interventions to prevent sexually transmitted infections, including HIV infection.Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania.Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected WomenSustained High HIV Incidence in Young Women in Southern Africa: Social, Behavioral, and Structural Factors and Emerging Intervention ApproachesMedroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro.Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007.Medroxyprogesterone acetate impairs human dendritic cell activation and function.Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.Genital infections and syndromic diagnosis among HIV-infected women in HIV care programmes in Kenya.
P2860
Q21090622-7FE0F2AA-0AF3-4429-A700-90376BE78D8CQ21144588-5713B98E-128E-484F-833E-EC1C818A88FBQ24194597-2461E450-7233-426E-9D5B-3440F2FF1B1DQ24201661-D041AB66-8479-41CE-A5B0-29C7398BE778Q27012918-4A38007D-B7B8-4E1D-847C-F62073EB7C9AQ27026257-E7AA3409-B24B-4265-AE6D-09FF01CC535CQ27027323-00522814-6557-4820-BA00-CC80DFEE6C23Q27311833-DBFF04E5-3FD7-4A70-8836-26F44EF12DEEQ27690876-6BA43D55-5493-46DF-BE17-14B19D0C7047Q28743488-0B5147AB-E78A-4FAC-B3C1-9E2B62159ABDQ30356708-E3A24649-2A4F-434B-A7C3-76A042E1E6ADQ30416473-FADD12A0-3FA8-41CB-A7A2-87AF377E452BQ30447923-4ED59CC4-D697-472F-8EB4-B5254387BBBFQ30660068-A4016C5E-244A-403B-8D7D-200D8DAC3F87Q31014284-CD275586-205C-4846-903E-A233DC34AA3AQ33552342-D5F133FC-1F62-42BD-A10C-47A850639321Q33553821-03B6D5AE-826B-490F-84BA-0999F767E63AQ33617817-5F212EC8-EA44-4E98-AFFC-17524C9B3D7BQ33723224-1D2C3353-F1A5-4AC2-AC31-5FEF6412DDB7Q33753930-2B2B74DC-4A0D-4F0E-A872-AE87DA3DF074Q33763511-6AC6A0DE-A4EA-4662-B19A-DDAA1A205691Q34111702-72741D2E-EA27-42C0-AED5-5620E216B634Q34123283-B4DF74D9-7813-4A5F-AD5C-4616F071E0C4Q34457619-9D1A680F-C56E-436E-A8A3-601AB0769ED1Q34649232-EE8B0AED-C944-4CA6-A2E8-CBF5CFBEE318Q34675983-55F67C18-9CDD-4C70-A3D1-68D91EAA9511Q34679705-3ED01CF3-F04C-4889-BF34-B004D875130DQ34700364-5595F39F-5AF0-40D1-A84A-8E6A461B5D6AQ35172396-5A4D67FA-4304-4D84-891E-BF794609E1D6Q35542152-040847CE-841B-462F-9C25-925A15D0AE27Q35571202-371BB45D-6AA9-4D43-9CED-A45F5019040DQ35582308-5731C3F6-EDF6-4817-8DB7-46A6DBBC4B53Q35602771-CBD669A1-FA4C-4FDC-BBA3-C9E478DAF691Q35676330-2FB69529-91B5-4D3E-9289-417F470306C1Q35699938-53640954-D36E-4960-B4B3-0EDF95C1D556Q35739600-96003CDE-9072-4EC8-A5C0-6400DA616272Q35784803-2D39DA3D-62AE-4A59-BA14-3F75BFD2FF10Q35814961-C58DD50E-26E4-4EAC-A37B-DD6909436B10Q35817142-E44AF2BE-9AC7-49F2-A2EF-4A092267E6DCQ35880422-C90D883A-3DFF-4424-9173-47C251BA5D72
P2860
Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hormonal contraceptive use, he ...... cquisition among Kenyan women.
@en
type
label
Hormonal contraceptive use, he ...... cquisition among Kenyan women.
@en
prefLabel
Hormonal contraceptive use, he ...... cquisition among Kenyan women.
@en
P2093
P1433
P1476
Hormonal contraceptive use, he ...... cquisition among Kenyan women.
@en
P2093
Jared M Baeten
Jeckoniah O Ndinya-Achola
Kishorchandra Mandaliya
Ludo Lavreys
R Scott McClelland
Sarah Benki
Vrasha Chohan
P304
P356
10.1097/QAD.0B013E328270388A
P407
P577
2007-08-01T00:00:00Z